Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
U.S. halts new research grants to Harvard amid compliance dispute over alleged violations and antisemitic incidents on campus.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
U.S. halts new research grants to Harvard amid compliance dispute over alleged violations and antisemitic incidents on campus.